ClinicalTrials.gg
RecruitingNCT07846878Updated Oct 15, 2026

Prospective External Validation of an Early Prediction Model for Adverse Postoperative Pain Trajectories After Orthopedic Surgery

An observational study in Postoperative Pain, sponsored by First Affiliated Hospital of Chongqing Medical University. Recruiting at 1 site in China. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-10-15.

Sponsored by First Affiliated Hospital of Chongqing Medical University · Observational

How we know

From the registry’s dates

  • Started Oct 2026; still recruiting 1 month later.
Updated Oct 15, 2026Now RecruitingSite recruiting status changed+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
400
Ages
18 Years to 90 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 249 studies in Pain, Postoperative with a site in China — 79 open to participants now, 81 under way, 3 of them phase 3. Pain, Postoperative · China.

Planned enrollment
20th of 43
400 · median 350
Started
2026
with 35 others
Observational
43 of 249
14 open now
Primary completion
2027-12
later than 71 of 80 live
Registered
247th of 249
by date
Lead sponsor
6 of 249
First Affiliated Hospital of Chongqing Medical University

Among the 249 studies in Pain, Postoperative with a site in China, this one is the 20th largest by planned enrollment of the 43 observational ones that give a count, is one of 36 that started in 2026, is one of 43 observational ones, reaches primary completion later than 71 of the 80 other live ones, and was the 247th registered.

Pain, Postoperative

5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

79 of the 249 studies in Pain, Postoperative with a site in China are open now. Recruiting first, the newest first:

73 more — sign in →

All 79 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.

This study: 18 Years to 90 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 249 studies in Pain, Postoperative with a site in China, or all of them as a file.
02

Study summary

This prospective observational study will externally validate a previously developed and locked prediction model for identifying adult patients at risk of adverse postoperative pain trajectories after elective orthopedic surgery. Approximately 400 patients will be consecutively recruited at the First Affiliated Hospital of Chongqing Medical University.

Postoperative pain will be assessed during the first 48 hours after surgery using the 0-10 Numeric Rating Scale. Pain scores will be organized into eight consecutive 6-hour time windows to determine each participant's postoperative pain trajectory according to prespecified rules. Clinical information available at the predefined prediction time point will be entered into the locked prediction model to calculate each participant's predicted probability of an adverse pain trajectory.

The study will evaluate the model's discrimination, calibration, overall prediction performance, and potential clinical utility. The model will not be modified or retrained using data from this validation cohort. Individual prediction results will not be provided to patients or treating clinicians and will not be used to guide treatment during the study.

Read the detailed description

This is a single-center, prospective, observational external validation study of an early prediction model for adverse postoperative pain trajectories in adult patients undergoing elective orthopedic surgery at the First Affiliated Hospital of Chongqing Medical University.

Eligible participants will receive routine perioperative care. The study will not assign any experimental treatment or alter the participants' surgical, anesthetic, analgesic, nursing, or rehabilitation management. Study personnel will collect prespecified clinical variables from patient interviews, electronic medical records, anesthesia information systems, nursing records, and standardized postoperative pain assessments.

The end of surgery will be defined as postoperative hour 0. Postoperative pain intensity will be assessed using the 0-10 Numeric Rating Scale during the first 48 hours after surgery. This period will be divided into eight consecutive 6-hour windows: 0-6, 6-12, 12-18, 18-24, 24-30, 30-36, 36-42, and 42-48 hours. When more than one valid pain score is available within a time window, the median value will be used for the primary analysis.

Before enrollment of the first participant, the prediction model, prediction time point, predictor definitions, variable coding, data-processing procedures, missing-data handling rules, model structure, model parameters and hyperparameters, and outcome classification rules will be locked. Data from the external validation cohort will not be used to reselect predictors, retune hyperparameters, redefine cutoffs, or otherwise modify the original model.

After completion of the 48-hour observation period and data verification, each participant's probability of developing an adverse postoperative pain trajectory will be calculated using the locked model. The observed postoperative pain trajectory will be determined independently according to the prespecified trajectory classification and mapping rules.

External model performance will be evaluated using the area under the receiver operating characteristic curve, Brier score, calibration curve, calibration intercept, and calibration slope. Additional analyses will include sensitivity, specificity, positive predictive value, negative predictive value, accuracy, and decision curve analysis at prespecified risk thresholds. Exploratory analyses may describe model performance across major orthopedic surgical categories.

Model predictions will be calculated offline and will not be communicated to participants, surgeons, anesthesiologists, nurses, or other treating clinicians during the study. Prediction results will therefore not influence clinical management.

03

Conditions studied

  • Postoperative Pain

Browse trials for

Keywords

  • Postoperative Pain
  • Pain Trajectory
  • Orthopedic Surgery
  • Prediction Model
  • External Validation
  • Prospective Cohort
  • Clinical Prediction Model
04

Who can participate

The criteria were revised on the registry on Oct 15, 2026. See what changed

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients undergoing elective orthopedic surgery at the First Affiliated Hospital of Chongqing Medical University who are expected to remain hospitalized for at least 48 hours after surgery. Eligible procedures include major categories of elective orthopedic surgery, such as spinal surgery, hip or knee arthroplasty, pelvic or extremity fracture fixation, and orthopedic corrective surgery. Participants will be prospectively and consecutively screened and enrolled according to the prespecified eligibility criteria.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18 to 90 years, regardless of sex.
  • Scheduled to undergo an eligible elective orthopedic surgical procedure at the First Affiliated Hospital of Chongqing Medical University.
  • Expected to remain hospitalized for at least 48 hours after surgery.
  • Conscious before surgery, with sufficient understanding and communication ability to understand and complete the 0-10 Numeric Rating Scale for pain.
  • Able and willing to provide written before any study-specific data collection.

Exclusion criteria

Exclusion Criteria:

  • Younger than 18 years or older than 90 years.
  • Emergency surgery, unplanned surgery, or a surgical procedure outside the prespecified orthopedic surgical scope of the study.
  • Unable to reliably understand the study or complete the Numeric Rating Scale because of impaired consciousness, severe cognitive impairment, psychiatric disorder, persistent deep sedation, mechanical ventilation, severe hearing impairment, language or communication difficulties, or similar conditions.
  • Lacks full capacity to provide valid .
  • Concurrent participation in another clinical study that may affect pain assessment, analgesic treatment, or study outcomes.
  • Expected discharge or transfer within 48 hours after surgery, or inability to complete the main study observation because of clinical circumstances.
  • Any other condition that, in the investigator's judgment, makes the patient unsuitable for participation in the study.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
400 participants (estimated)
Patient registry
No

Groups and cohorts

  • Prospective External Validation Cohort

    Adult patients undergoing elective orthopedic surgery at the First Affiliated Hospital of Chongqing Medical University will be prospectively enrolled and followed for 48 hours after surgery. Postoperative pain scores and prespecified clinical variables will be collected according to the study protocol. All participants will receive routine perioperative care, and no treatment will be assigned or modified by the study investigators. The locked prediction model will be applied offline to evaluate the risk of an adverse postoperative pain trajectory.

    Procedure: Elective Orthopedic Surgery

Interventions

  • ProcedureElective Orthopedic Surgery

    Participants will undergo elective orthopedic surgery as part of routine clinical care. The surgical procedure, anesthetic management, postoperative analgesia, nursing care, and rehabilitation plan will be determined by the treating clinical team according to standard practice. The study investigators will not assign, modify, or influence these treatments. The study will prospectively collect prespecified perioperative variables and postoperative pain assessments for external validation of a locked prediction model.

06

What researchers measure

Primary outcomes

  1. Proportion of Participants With an Adverse Postoperative Pain Trajectory

    Participants will be classified as having an adverse or non-adverse postoperative pain trajectory based on pain scores collected during the first 48 hours after surgery and the prespecified, locked trajectory classification and mapping rules. The number and percentage of participants classified as having an adverse postoperative pain trajectory will be reported.

    Time frame: From the end of surgery through 48 hours postoperatively

Secondary outcomes

  1. Area Under the Receiver Operating Characteristic Curve (AUC)

    The area under the receiver operating characteristic curve (AUC) will be used to assess the discrimination of the locked prediction model for distinguishing participants with and without an adverse postoperative pain trajectory. The AUC ranges from 0.5, indicating no discrimination, to 1.0, indicating perfect discrimination. The AUC and its 95% confidence interval will be reported.

    Time frame: Through 48 hours postoperatively

  2. Brier Score

    The Brier score will be used to evaluate the overall predictive performance of the locked prediction model by comparing predicted probabilities with the observed binary adverse postoperative pain trajectory outcome. Lower values indicate better overall predictive performance. The Brier score and its 95% confidence interval will be reported.

    Time frame: Through 48 hours postoperatively

  3. Calibration Intercept

    Calibration intercept will be used to assess systematic overestimation or underestimation of predicted risk by the locked prediction model. A value of 0 indicates ideal calibration. The calibration intercept and its 95% confidence interval will be reported.

    Time frame: Through 48 hours postoperatively

  4. Calibration Slope

    Calibration slope will be used to assess the agreement between the spread of predicted probabilities and observed outcomes. A value of 1 indicates ideal calibration. The calibration slope and its 95% confidence interval will be reported.

    Time frame: Through 48 hours postoperatively

  5. Calibration Curve

    A calibration curve will be used to visually assess agreement between predicted probabilities of an adverse postoperative pain trajectory and observed outcome frequencies across the range of predicted risk. The calibration curve and its 95% confidence interval will be presented.

    Time frame: Through 48 hours postoperatively

  6. Classification Performance at the Prespecified Risk Threshold

    Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of the locked prediction model will be evaluated at the prespecified risk threshold and reported with 95% confidence intervals where applicable. The threshold will not be selected or optimized using the external validation cohort.

    Time frame: Through 48 hours postoperatively

  7. Decision Curve Analysis

    Decision curve analysis will be used to evaluate the clinical net benefit of the locked prediction model across a prespecified range of clinically relevant risk thresholds, compared with strategies of treating all participants or treating no participants as being at increased risk.

    Time frame: Through 48 hours postoperatively

  8. Distribution and Characteristics of Postoperative Pain Trajectory Classes

    The number and percentage of participants assigned to each prespecified postoperative pain trajectory class will be described. Class-specific mean pain trajectories over the first 48 postoperative hours and prespecified indicators of classification uncertainty will also be summarized.

    Time frame: From the end of surgery through 48 hours postoperatively

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be shared with external researchers because the study involves sensitive patient-level clinical information and is subject to institutional data protection and confidentiality requirements. Study data will be securely stored and accessible only to authorized study personnel. Aggregated, de-identified study findings will be disseminated through peer-reviewed scientific publications. Any future change to the IPD sharing plan will be subject to applicable ethical and institutional approvals.

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2026 (actual). Primary completion is estimated for Dec 2027, 14 months after the start.

Of 392 non-industry observational studies under Pain, Postoperative, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 32. This study's planned 14 months is above that.

Counting every sponsor, half of 396 studies reached it within 13 months; a quarter within 6 and three quarters within 33.

Start moved once since we started tracking on Sep 25, 2026: Sep 2026 → Oct 2026, on Oct 15, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Sep 23, 2026
First posted
Sep 29, 2026
StartActual
Oct 7, 2026was Sep 2026
Primary completionEst.
Dec 2027
CompletionEst.
Dec 2027
Last update
Oct 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 15, 2026
Sites
The First Affiliated Hospital of Chongqing Medical University is now Recruiting
Oct 15, 2026
Start date
Sep 2026→Oct 7, 2026 (actual)
Oct 15, 2026
Eligibility
4 exclusion criteria edited, 1 added
What changed in the criteria
Exclusion criteria
  • EditedUnable to reliably understand the study or complete the Numeric Rating (4)Scale because of impaired consciousness, severe cognitive impairment, psychiatric disorder, persistent deep sedation, mechanical ventilation, severe hearing impairment, language or communication difficulties, or similar conditions.
  • AddedLacks full capacity to provide valid informed consent.
  • Edited(5)Lacks full capacity to provide valid informed consent. (6)Concurrent participation in another clinical study that may affect pain assessment, analgesic treatment, or study outcomes.
  • Edited(7)Expected discharge or transfer within 48 hours after surgery, or inability to complete the main study observation because of clinical circumstances.
  • Edited(8)Any other condition that, in the investigator's judgment, makes the patient unsuitable for participation in the study.
Oct 15, 2026
Registered
First appeared on the registry
Sep 29, 2026
Show all 2 updates
  1. Oct 15, 2026
    Not yet recruiting→Recruiting
    The First Affiliated Hospital of Chongqing Medical University is now Recruiting
    Start date Sep 2026→Oct 7, 2026 (now actual)
    Eligibility 4 exclusion criteria edited, 1 added
    What changed in the criteria
    Exclusion criteria
    • EditedUnable to reliably understand the study or complete the Numeric Rating (4)Scale because of impaired consciousness, severe cognitive impairment, psychiatric disorder, persistent deep sedation, mechanical ventilation, severe hearing impairment, language or communication difficulties, or similar conditions.
    • AddedLacks full capacity to provide valid informed consent.
    • Edited(5)Lacks full capacity to provide valid informed consent. (6)Concurrent participation in another clinical study that may affect pain assessment, analgesic treatment, or study outcomes.
    • Edited(7)Expected discharge or transfer within 48 hours after surgery, or inability to complete the main study observation because of clinical circumstances.
    • Edited(8)Any other condition that, in the investigator's judgment, makes the patient unsuitable for participation in the study.
    + 2 other changes: verification date and data sharing statement
  2. Sep 29, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07846878
Lead sponsor
First Affiliated Hospital of Chongqing Medical University
Responsible party
Lihua Peng (Associate Professor and Chief Physician, First Affiliated Hospital of Chongqing Medical University) — Principal investigator
First posted
Sep 29, 2026
Start date
Oct 7, 2026
Primary completion
Dec 2027 (estimated)
Completion
Dec 2027 (estimated)
Last update
Oct 15, 2026

Study contacts

Lihua Peng
Contact
plhcqmu@163.com
+86 15823443968

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion